U.S. Federal and State Cases, Codes, and Articles
Select a tab to search United States Cases, Codes, or Articles
U.S. Federal and State Cases, Codes, and Articles
Select a tab to search United States Cases, Codes, or Articles
Search for cases
Indicates required field
Search by keyword or citation
Indicates required field
Search blogs, article pages, and cases and codes
Indicates required field
Current as of January 01, 2022 | Updated by FindLaw Staff
(a) Team established.--The department shall establish a Medication Death and Incident Review Team and conduct a review and shall examine the circumstances surrounding medication-related deaths and medication-related incidents in this Commonwealth for the purpose of promoting safety, reducing medication-related deaths and medication-related incidents and improving treatment practices.
(b) Composition.--The team shall consist of the following individuals:
(1) The secretary or a designee, who shall serve as the chairperson of the team.
(2) The Director of the Bureau of Drug and Alcohol Programs.
(3) The following individuals appointed by the secretary:
(i) A representative from an opioid-assisted treatment program.
(ii) A representative from a licensed drug and alcohol addiction treatment program that is not defined as an opioid-assisted treatment program.
(iii) A representative from law enforcement recommended by a Statewide association representing members of law enforcement.
(iv) A representative from the medical community recommended by a Statewide association representing physicians.
(v) A district attorney recommended by a Statewide association representing district attorneys.
(vi) A coroner or medical examiner recommended by a Statewide association representing county coroners and medical examiners.
(vii) A member of the public.
(viii) A patient or family advocate.
(ix) A representative from a recovery organization.
(x) An office-based agonist treatment provider who is assigned a waiver from the Drug Enforcement Administration, including a special identification number, commonly referred to as the “X” DEA number, to provide office-based prescribing of buprenorphine.
(xi) A representative of the Department of Health who is affiliated with the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) established under the act of October 27, 2014 (P.L. 2911, No. 191), 1 known as the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act.
(xii) A toxicologist.
(c) Initial meeting.--The initial meeting of the team shall take place within 90 days of the effective date of this section. During this initial meeting, the team shall develop a schedule for its work and reports.
(d) Expenses.--Members of the team shall not receive compensation but shall be reimbursed for necessary travel and other reasonable expenses incurred in connection with the performance of their duties as members. If possible, the team shall utilize the services and expertise of existing personnel and staff of State government.
Cite this article: FindLaw.com - Pennsylvania Statutes Title 71 P.S. State Government § 1691.3. Establishment of Medication Death and Incident Review Team - last updated January 01, 2022 | https://codes.findlaw.com/pa/title-71-ps-state-government/pa-st-sect-71-1691-3/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
Response sent, thank you
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)